AML digital therapeutic lands Breakthrough Device Designation from FDA January 17, 2022 Auto Bot Clinical Development 0 Blue Note Therapeutics has announced the status has been granted to BNT200, a device to treat anxiety and depression in acute myeloid leukemia patients.
